Hunger Perception and Weight-Related Outcomes Following Use of a Leptin-Supporting Dietary Supplement
Efforia, Inc · NCT07442864
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- September 10, 2025
- Record last updated
- March 2, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study evaluates changes in hunger perception and body composition-related measures following daily use of a commercially available dietary supplement formulated to support leptin-related metabolic signaling. Adult participants will self-administer the supplement for 12 weeks and complete periodic self-reported assessments related to appetite, hunger, and weight-related outcomes. Participants serve as their own control, with comparisons made between baseline and follow-up measurements. The study is designed to generate preliminary, real-world evidence regarding supplement use in a general wellness context.
Being studied: Leptin Balance Formula
Conditions: Hunger; Weight Change
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Adults aged 18 years or older
- Willing to pay for study supplies and able to take the dietary supplement daily for 12 weeks
- Willing to complete electronic questionnaires and self-reported measurements
- Able to provide informed consent
Exclusion Criteria
- Pregnant or breastfeeding individuals
- Known allergy or sensitivity to any supplement ingredients
- Use of medications or supplements that could interfere with appetite or weight without medical clearance
- Any medical condition that would make participation unsafe, as determined by the participant
Recruiting US locations
Efforia
New York, NY 10003
Site contact: Matthew Amsden · (646) 679-2479 · help@efforia.com
Study contacts (from the official record)
- Matthew Amsden · 646-679-2479 · help@efforia.com
Similar studies in New York
All weight loss studies in New York →- RecruitingHealthy volunteersPhase 1
Alpelisib Challenge Test (ACT)
Columbia University
- Location
- New York, NY
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1
Human Models of Selective Insulin Resistance: Alpelisib, Part I
Columbia University
- Location
- New York, NY
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- The Bronx, NY + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 3
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Amgen
- Location
- New York, NY + 51 other US sites
- Eligibility basics
- Ages 18–99